Skip to main content
logo
Radiopharm Theranostics Limited (ASX:RAD)
Australia flag Australia · Delayed Price · Currency is AUD
0.0280
+0.0010 (3.70%)
Aug 29, 2025, 3:37 PM AEST

Radiopharm Theranostics Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Revenue
3.630.30.29--
Other Revenue
9.911.665.92--
Revenue
13.541.966.21--
Revenue Growth (YoY)
591.26%-68.46%---
Cost of Revenue
3.5921.6119.537.49-
Gross Profit
9.94-19.65-13.32-7.49-
Selling, General & Admin
14.6413.0412.237.640.3
Research & Development
27.52----
Operating Expenses
44.0515.6815.2712.441.16
Operating Income
-34.1-35.33-28.59-19.93-1.16
Interest Expense
-0.07-0.64-0.09-9.35-
Interest & Investment Income
-0.050.150.01-
Currency Exchange Gain (Loss)
-0.09-0.26-1.11-0
EBT Excluding Unusual Items
-34.17-35.83-28.79-30.38-1.16
Gain (Loss) on Sale of Assets
--1.69---
Asset Writedown
--1.48-3.1--
Other Unusual Items
-4.07-8.86-2.68--
Pretax Income
-38.24-47.85-34.57-30.38-1.16
Income Tax Expense
0.10.10.040.04-
Earnings From Continuing Operations
-38.34-47.95-34.61-30.42-1.16
Minority Interest in Earnings
1.64----
Net Income
-36.7-47.95-34.61-30.42-1.16
Net Income to Common
-36.7-47.95-34.61-30.42-1.16
Shares Outstanding (Basic)
2,085386306181-
Shares Outstanding (Diluted)
2,085386306181-
Shares Change (YoY)
439.62%26.36%68.74%--
EPS (Basic)
-0.02-0.12-0.11-0.17-
EPS (Diluted)
-0.02-0.12-0.11-0.17-
Free Cash Flow
-36.65-22.98-23.25-9.91-0.08
Free Cash Flow Per Share
-0.02-0.06-0.08-0.06-
Gross Margin
73.45%--214.52%--
Operating Margin
-251.91%-1803.82%-460.41%--
Profit Margin
-271.10%-2448.23%-557.36%--
Free Cash Flow Margin
-270.68%-1173.12%-374.36%--
EBITDA
-30.98-32.2-25.29-16.94-
EBITDA Margin
-228.81%----
D&A For EBITDA
3.133.133.32.98-
EBIT
-34.1-35.33-28.59-19.93-1.16
EBIT Margin
-251.91%----
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.